Canton Strategic Holdings (CNTN) Research & Development (2021 - 2026)

Canton Strategic Holdings (CNTN) reported Research & Development of $267823.0 for Q1 2026, down 54.92% on a YoY basis from $594070.0 in Q1 2025, and down 83.83% quarter-over-quarter from $1.7 million in Q4 2025.

Canton Strategic Holdings (CNTN) Research & Development (2021 - 2026) Analysis & Trends

Canton Strategic Holdings has reported Research & Development for 6 years, with the latest figure at $267823.0 in Q1 2026.

  • For the quarter ending Q1 2026, Research & Development fell 54.92% year-over-year to $267823.0; the trailing twelve-month figure through Mar 2026 stood at $2.7 million (down 53.9% YoY), and the FY2025 full-year result was $3.1 million, down 51.91% from the prior year.
  • Research & Development for Q1 2026 stood at $267823.0, down from $1.7 million in the prior quarter.
  • The five-year high for Research & Development was $2.3 million in Q3 2024, with the low at $267823.0 in Q1 2026.
  • Historically, Research & Development has averaged $915996.6 across 5 years, with a median of $831844.0 in 2022.
  • Annual changes were most pronounced in 2022 — Research & Development soared 1766.15% — and 2025, when it sank 87.83%.
  • Canton Strategic Holdings' Research & Development stood at $683205.0 in 2022, then soared by 45.3% to $992725.0 in 2023, then jumped by 110.07% to $2.1 million in 2024, then declined by 20.6% to $1.7 million in 2025, then slumped by 83.83% to $267823.0 in 2026.
  • The last three Research & Development figures came in at $267823.0 (Q1 2026), $1.7 million (Q4 2025), and $277803.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 4.32 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 15.66 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 626,092.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -101.30 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -2.30 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 1.46 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 357,444.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 961.60 Mn
9 Abivax 91.96 Bn 91.96 Bn - -58.00 Mn
10 Canton Strategic Holdings 699.97 Mn 658.44 Mn - 267,823.00

Historic Data

Download Data
DateValue
Mar 31, 2026 267,823.00
Dec 31, 2025 1.66 Mn
Sep 30, 2025 277,803.00
Jun 30, 2025 546,204.00
Mar 31, 2025 594,070.00
Dec 31, 2024 2.09 Mn
Sep 30, 2024 2.28 Mn
Jun 30, 2024 999,553.00
Mar 31, 2024 1.03 Mn
Dec 31, 2023 992,725.00
Sep 30, 2023 488,177.00
Jun 30, 2023 1.03 Mn
Mar 31, 2023 1.05 Mn
Dec 31, 2022 683,205.00
Sep 30, 2022 831,844.00
Jun 30, 2022 455,546.00
Mar 31, 2022 307,829.00
Dec 31, 2021 -41,005.00
Sep 30, 2021 313,133.00
Jun 30, 2021 674,765.00